We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Enzyme Discovered May Lead to Better TB Test

By LabMedica International staff writers
Posted on 31 Jan 2013
An enzyme has been identified that will trigger the rapid breakdown of several Mycobacteria, which could lead to better tests for the deadly tuberculosis infection.

The current bacterial culture test for tuberculosis infections is highly accurate but time-consuming, taking up to several weeks, while the diagnostic process called nucleic acid-based amplification (NAA) faces difficulty in breaking open, or lysing bacteria. More...


Scientists at University of Pittsburgh Graduate School of Public Health (PA, USA) show that exposure to an enzyme called esterase from Mycobacterium smegmatis hydrolyzes the ester linkage of trehalose dimycolate in vitro, which triggers the rapid and efficient lysis of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium marinum.

A rapid and efficient lysis of trehalose dimycolate hydrolase (TDMH) exposed M. tuberculosis, and a subsequent release of nucleic acids (NA) offered a unique opportunity to use this enzyme for achieving more sensitive detection in a nucleic acid amplification assay for the diagnosis of tuberculosis (TB). The nucleic content in the supernatant of TDMH-exposed bacilli started to increase within 30 minutes of exposure, and it peaked at around 60 minutes.

Treatment of samples with TDMH prior to the amplification reaction facilitated the NA detection in 37 samples, a highly significant improvement in the numbers of positive detection. The investigators also demonstrated that this quick lysis of M. tuberculosis improved its detection at lower density.

Anil Ojha, PhD, an assistant professor and senior author of the study said, "Tuberculosis is a huge public health burden. Clearly, controlling the infection is heavily dependent upon an effective diagnosis. Discovery of enzyme-based mycobacteria lysis has the potential to increase the sensitivity of NAA." The study was published on January 4, 2013, in the Journal of Biological Chemistry.

Related Links:
University of Pittsburgh


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.